ANEB - Anebulo Pharmaceuticals GAAP EPS of -$0.11 misses by $0.01 November, 10 2022 09:46 AM Anebulo Pharmaceuticals Inc. Anebulo Pharmaceuticals press release ( NASDAQ: ANEB ): Q1 GAAP EPS of -$0.11 misses by $0.01 . Cash was $19.2 million as of September 30, 2022. For further details see: Anebulo Pharmaceuticals GAAP EPS of -$0.11 misses by $0.01